Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: HIV Med. 2017 Apr 26;18(6):412–418. doi: 10.1111/hiv.12518

Table 1.

Subject characteristics

Characteristic Cohort 1 (n = 10) Cohort 2 (n = 10) Cohort 3 (n = 10)

Age – years
 Mean 43.2 37.2 20.4
 Range 22–53 25–53 18–23

Sex – number
 Male 4 8 10
 Female 5 2 0
 Transgender (M to F) 1 0 0

Race – number
 African American 7 3 9
 Caucasian 3 6 0
 Other 0 1 1

HIV status – %
 HIV-positive 100 0 0

ART regimen N/A N/A
 Atripla 7
 Stribild 2
 Complera 1